Specifically, USP39 promotes HCC progression by inhibiting the degradation of ZEB1 through its deubiquitylation function, whereas TRIM26 exerts tumor suppressor functions by ubiquitinating degraded ZEB1. Here, USP39 is linked to hepatocellular carcinoma.